Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase | 0 | 1 | 0 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
TDP1 protein | 2 | 0 | 0 | 2 |
AR protein | 3 | 0 | 0 | 3 |
Smad3 | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 1 | 0 | 0 | 1 |
glucocorticoid receptor [Homo sapiens] | 2 | 0 | 0 | 2 |
retinoid X nuclear receptor alpha | 3 | 0 | 0 | 3 |
estrogen-related nuclear receptor alpha | 2 | 0 | 0 | 2 |
estrogen nuclear receptor alpha | 3 | 0 | 0 | 3 |
G | 1 | 0 | 0 | 1 |
67.9K protein | 2 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
peroxisome proliferator activated receptor gamma | 2 | 0 | 0 | 2 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 2 | 0 | 0 | 2 |
geminin | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 0 | 0 | 2 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 4 | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 2 | 0 | 2 |
Bile salt export pump | 0 | 2 | 0 | 2 |
Interferon beta | 1 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 0 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 0 | 0 | 2 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 0 | 0 | 2 |
GABA theta subunit | 2 | 0 | 0 | 2 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 0 | 0 | 2 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
Chain A, Inosine-5'-Monophosphate Dehydrogenase 2 | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
glp-1 receptor, partial | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 1 | 0 | 0 | 1 |
SMAD family member 2 | 1 | 0 | 0 | 1 |
SMAD family member 3 | 1 | 0 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 3 | 0 | 0 | 3 |
estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 2 | 0 | 0 | 2 |
progesterone receptor | 1 | 0 | 0 | 1 |
farnesoid X nuclear receptor | 1 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 2 | 0 | 0 | 2 |
aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 1 | 0 | 0 | 1 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
Histone H2A.x | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 | 1 | 0 | 0 | 1 |
survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
Cellular tumor antigen p53 | 1 | 0 | 0 | 1 |
Inosine-5'-monophosphate dehydrogenase 2 | 0 | 2 | 0 | 2 |
Glutamate receptor 1 | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 1 | 1 | 0 | 2 |
Glutamate receptor 3 | 0 | 1 | 0 | 1 |
Glutamate receptor 4 | 0 | 1 | 0 | 1 |
Inosine-5'-monophosphate dehydrogenase 1 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A1 | 0 | 0 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
Alpha-synuclein | 1 | 0 | 0 | 1 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
Ataxin-2 | 1 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1A7 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1A10 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 1 |
Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
GLI family zinc finger 3 | 1 | 0 | 0 | 1 |
retinoic acid nuclear receptor alpha variant 1 | 1 | 0 | 0 | 1 |
pregnane X nuclear receptor | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 1 | 0 | 0 | 1 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |